Shih-Ying Lee

Title: Innovations of Shih-Ying Lee: A Pioneer in Radiotherapy Medicine

Introduction

Shih-Ying Lee is a prominent inventor hailing from Taoyuan, Taiwan, known for his contributions to the field of medicine with a focus on radiotherapy for cancer treatment. With a total of five patents to his name, he has made significant strides in developing innovative therapies targeting prostate cancer and other conditions.

Latest Patents

Among his latest patents is a groundbreaking invention titled "PSMA targeted radiotherapy medicine and preparation method thereof." This invention features a novel precursor designed for radioisotope labeling with ligands aimed at specifically binding prostate-specific membrane antigen (PSMA) for the diagnosis and treatment of prostate cancer. The pharmacophore developed by Lee encompasses three molecules of glutamic acid, urea, and lysine, integrated with variable linkers determined by the pharmacological activity of the PSMA inhibitor. This innovation facilitates labeling with radioactive isotopes such as Ga-67, Ga-68, In-111, Lu-177, Cu-64, and Y-90 through a chelating agent, enabling imaging analysis of human tumor models and functioning as a PSMA-targeted radioligand therapy for prostate cancer diseases.

Another important patent of his includes "Compound or its salt thereof targeting fibroblast activation protein, its preparation methods and its uses thereof." This disclosure pertains to a compound or its salt that targets fibroblast activation protein, detailing its preparation methods and practical applications. The compound represented by the formula (I) D-R1-R2-A-R' or its salt has notable implications for therapeutic use.

Career Highlights

Shih-Ying Lee has worked at esteemed institutions such as the Institute of Nuclear Energy Research under the Atomic Energy Council, Executive Yuan, R.O.C. His roles at these organizations have allowed him to research and develop innovative medical technologies with a strong emphasis on nuclear medicine and radiotherapy.

Collaborations

Throughout his career, Lee has collaborated with several talented individuals, including colleagues such as Sheng-Nan Lo and Su-Jung Chen. These collaborations have contributed significantly to his work and the development of effective treatments in the realm of cancer therapy.

Conclusion

In conclusion, Shih-Ying Lee stands out as a visionary inventor in medical technology, particularly in the field of radiotherapy. His patented inventions reflect his commitment to advancing cancer treatment options, and his influential collaborations demonstrate the importance of teamwork in achieving significant medical breakthroughs.